Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-03

FDA Approved: ZUBSOLV — Original Application (Orexo US, Inc.)

View source ↗

Summary

FDA approved ZUBSOLV (buprenorphine hydrochloride and naloxone hydrochloride) from Orexo US, Inc. under its Original Application (NDA204242) for the treatment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZUBSOLV (Buprenorphine hydrochloride and naloxone hydrochloride)

Snippet

ORIG AP for ZUBSOLV (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)